[The role of prophylactic use of pegylated recombinant human granulocyte colony-stimulating factor(PEG-rhG-CSF) in breast cancer receiving adjuvant chemotherapy].

Zhang, J Y; Liu, Y X; Wang, H; Mi, L; Song, G H; Jiang, H F; Yan, Y; Shao, B; Kong, W Y; Zhang, R Y; Ran, R; Liu, X R; Wang, J; Lin, Y T; Li, H P

Zhang, J Y; Liu, Y X; Wang, H; Mi, L; Song, G H; Jiang, H F; Yan, Y; Shao, B; Kong, W Y; Zhang, R Y; Ran, R; Liu, X R; Wang, J; Lin, Y T; Li, H P.

Afiliação

Zhang JY; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Zhonghua Yi Xue Za Zhi ; 98(34): 2718-2721, 2018 Sep 11.

Article em Zh | MEDLINE | ID: mdl-30220167

Assuntos

Neoplasias da Mama; Protocolos de Quimioterapia Combinada Antineoplásica; Quimioterapia Adjuvante; Fator Estimulador de Colônias de Granulócitos; Humanos; Polietilenoglicóis; Proteínas Recombinantes

Palavras-chave

Adjuvant chemotherapy; Breast neoplasms; Neutropenia; Pegylated recombinant human granulocyte colony-stimulating factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google